Jun 12, 2019 / 02:20PM GMT
Andrew Carter - Stifel Nicolaus & Company - Analyst
I think we will get started. Thanks for joining us, everybody, after a real fun evening last night, the Stifel Cross-Sector Insight Conference. My name is Andrew Carter. I'm the cannabis analyst here at Stifel. Some of our work is in the back, and of course, please reach out if you need anything.
Today we are hosting Tilray. Tilray is a global cannabis company seeking to be a leader in the research, cultivation, production, and distribution of cannabis. Tilray is building a global -- trusted global medical brand and is advantaged with a strong position in the Canadian market. The Company has signed partnerships with AB InBev, Associated Brands Group, and Novartis that really fuel the Company's position to capitalize on the global cannabis growth opportunity.
We are honored to host Tilray Founder, Chairman, and CEO, Brendan Kennedy. Brendan?
Brendan Kennedy - Tilray, Inc. - President and CEO
Thanks for being here today. I'm Brendan Kennedy. Nine years ago in May of 2010, I was in an office
Tilray Inc at Stifel Cross Sector Insight Conference Transcript
Jun 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers